Emergent BioSolutions
EBS
#6911
Rank
NZ$1.00 B
Marketcap
NZ$18.83
Share price
-4.71%
Change (1 day)
-6.78%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): NZ$0.28 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are NZ$0.75 Billion. In 2024 the company made an earning of -NZ$0.12 Billion, an increase over its 2023 earnings that were of -NZ$1.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.28 B-341.96%
2024 -NZ$0.12 Billion-88.82%
2023 -NZ$1.07 Billion242.73%
2022 -NZ$0.32 Billion-153.8%
2021 NZ$0.57 B-20.43%
2020 NZ$0.72 B278.02%
2019 NZ$0.19 B27.11%
2018 NZ$0.15 B-27.12%
2017 NZ$0.20 B17.21%
2016 NZ$0.17 B0.45%
2015 NZ$0.17 B73.51%
2014 NZ$0.10 B41.36%
2013 NZ$72 M35.2%
2012 NZ$53.26 M0.4%
2011 NZ$53.04 M-56.46%
2010 NZ$0.12 B76.73%
2009 NZ$68.93 M32.94%
2008 NZ$51.85 M-5.62%
2007 NZ$54.94 M
2005 NZ$79.55 M269.89%
2004 NZ$21.5 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$19.67 B 7,069.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.33 B 13,868.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.47 B 5,539.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$20.54 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.14 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.43 Billion-255.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.94 B 971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel